Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cross-sectional and longitudinal assessment of the association between DDR1 variants and processing speed in patients with early psychosis and healthy controls

  • Gas, Cinta
  • Ayesa-Arriola, Rosa
  • Vázquez-Bourgon, Javier
  • Crespo-Facorro, Benedicto
  • García-Gavilán, Jesús
  • Labad, Javier
  • Martorell, Lourdes
  • Muntané, Gerard
  • Sánchez-Gistau, Vanessa
  • Vilella, Elisabet
Recent evidence indicates that DDR1 participates in myelination and that variants of DDR1 are associated with decreased cognitive processing speed (PS) in schizophrenia (SZ). Here, we explored whether DDR1 variants were associated with PS in subjects diagnosed with an early psychosis (EP), a condition often preceding SZ. Data from two Spanish independent samples (from Reus and Santander) including patients with EP (n = 75 and n = 312, respectively) and healthy controls (HCs; n = 57 and n = 160) were analyzed. The Trail Making Test part A was used to evaluate PS. Participants underwent genotyping to identify DDR1 variants rs1264323 and rs2267641. Cross-sectional data were analyzed with general linear models and longitudinal data were analyzed using mixed models. We examined the combined rs1264323AA-rs2267641AC/CC genotypes (an SZ-risk combination) on PS. The SZ-risk combined genotypes were associated with increased PS in EP patients but not in HCs in the cross-sectional analysis. In the longitudinal analysis, the SZ-risk combined genotypes were significantly associated with increased PS in both HCs and EP patients throughout the 10-year follow-up but no genotype × time interaction was observed. These results provide further evidence that DDR1 is involved in cognition and should be replicated with other samples., The study was supported by grants from the Spanish Instituto de Salud Carlos III (ISCIII) cofounded by FEDER (PI12-02111 to E. Vilella, PI10-01607 to J Labad, PI14/00639 and PI14/00918 to B Crespo-Facorro), the Fundació ‘La Marató de TV3’ (092230/092231 to J Labad) and the Cerca Programme/Generalitat de Catalunya. Dr. Ayesa-Arriola is funded by a Miguel Servet contract from the ISCIII (CP18/00003), and Dr. Vázquez-Bourgon is funded by a Research Intensification contract (INT/A21/10 and INT/A20/04) from Fundación Instituto de Investigación Marqués de Valdecilla., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-specific association between the cortisol awakening response and obsessive-compulsive symptoms in healthy individuals

  • Melia, Cristian Sebastian|||0000-0001-6784-4185
  • Soria, Virginia|||0000-0001-6412-6831
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Cabezas, Ángel|||0000-0001-8114-0264
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Monreal Ortiz, Jose Antonio|||0000-0002-0906-927X
  • Crespo, José Manuel
  • Alonso, Pino|||0000-0002-5779-9111
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Palao, Diego|||0000-0002-3323-6568
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Labad, Javier|||0000-0003-2214-1886
Previous studies have shown associations between obsessive-compulsive disorder (OCD) and hypothalamic-pituitary-adrenal axis activity (HPA). We aimed to investigate the association between obsessive-compulsive (OC) symptoms and HPA axis functionality in a non-clinical sample and to explore whether there are sex differences in this relationship. One hundred eighty-three healthy individuals without any psychiatric diagnosis (80 men, 103 women; mean age 41.3 ± 17.9 years) were recruited from the general population. The Obsessive-Compulsive Inventory Revised (OCI-R) was used to assess OC symptoms. State-trait anxiety, perceived stress, and stressful life events were also assessed. Saliva cortisol levels were determined at 6 time points (awakening, 30 and 60 min post-awakening, 10:00 a.m., 23:00 p.m. and 10:00 a.m. the following day of 0.25 mg dexamethasone intake [that occurred at 23:00 p.m.]). Three HPA axis measures were calculated: cortisol awakening response (CAR), cortisol diurnal slope, and cortisol suppression ratio after dexamethasone (DSTR). Multiple linear regression analyses were used to explore the association between OC symptoms and HPA axis measures while adjusting for covariates. Our main analyses were focused on OCI-R total score, but we also explored associations with specific OC symptom dimensions. No significant differences were observed between males and females in OC symptoms, anxiety measures, stress, or cortisol measures. In the multiple linear regression analyses between overall OC symptoms and HPA axis measures, a female sex by OC symptoms significant interaction (standardized beta = - 0.322; p = 0.023) for the CAR (but not cortisol diurnal slope nor DSTR) was found. Regarding specific symptom dimensions, two other sex interactions were found: a blunted CAR was associated with obsessing symptoms in women, whereas a more flattened diurnal cortisol slope was associated with ordering symptoms in men. There are sex differences in the association between OC symptoms and HPA axis measures in healthy individuals.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Role of Sleep Quality, Trait Anxiety and Hypothalamic-Pituitary-Adrenal Axis Measures in Cognitive Abilities of Healthy Individuals

  • Labad, Javier|||0000-0003-2214-1886
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Monreal Ortiz, Jose Antonio|||0000-0002-0906-927X
  • Crespo, José Manuel
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Palao, Diego|||0000-0002-3323-6568
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Cabezas, Ángel|||0000-0001-8114-0264
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Martorell, Lourdes|||0000-0003-4999-2197
Sleep plays a crucial role in cognitive processes. Sleep and wake memory consolidation seem to be regulated by glucocorticoids, pointing out the potential role of the hypothalamic-pituitary-adrenal (HPA) axis in the relationship between sleep quality and cognitive abilities. Trait anxiety is another factor that is likely to moderate the relationship between sleep and cognition, because poorer sleep quality and subtle HPA axis abnormalities have been reported in people with high trait anxiety. The current study aimed to explore whether HPA axis activity or trait anxiety moderate the relationship between sleep quality and cognitive abilities in healthy individuals. We studied 203 healthy individuals. We measured verbal and visual memory, working memory, processing speed, attention and executive function. Sleep quality was assessed with the Pittsburgh Sleep Quality Index. Trait anxiety was assessed with the State-Trait Anxiety Inventory. HPA axis measures included the cortisol awakening response (CAR), diurnal cortisol slope and cortisol levels during the day. Multiple linear regression analyses explored the relationship between sleep quality and cognition and tested potential moderating effects by HPA axis measures and trait anxiety. Poor sleep quality was associated with poorer performance in memory, processing speed and executive function tasks. In people with poorer sleep quality, a blunted CAR was associated with poorer verbal and visual., memory and executive functions, and higher cortisol levels during the day were associated with poorer processing speed. Trait anxiety was a moderator of visual memory and executive functioning. These results suggest that subtle abnormalities in the HPA axis and higher trait anxiety contribute to the relationship between lower sleep quality and poorer cognitive functioning in healthy individuals.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Glycated Haemoglobin Is Associated With Poorer Cognitive Performance in Patients With Recent-Onset Psychosis

  • Montalvo, Itziar
  • González-Rodríguez, Alexandre|||0000-0003-1855-8566
  • Cabezas, Ángel|||0000-0001-8114-0264
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Solé Moix, Montserrat|||0000-0001-8871-2720
  • Algora, María José
  • Ortega, Laura
  • Martorell, Lourdes|||0000-0003-4999-2197
  • Sánchez Gistau, Vanessa|||0000-0002-8635-7144
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Labad, Javier|||0000-0003-2214-1886
Glucose abnormalities and cognitive alterations are present before the onset of schizophrenia. We aimed to study whether glucose metabolism parameters are associated with cognitive functioning in recent-onset psychosis (ROP) patients while adjusting for hypothalamic-pituitary adrenal (HPA) axis measures. Sixty ROP outpatients and 50 healthy subjects (HS) were studied. Cognitive function was assessed with the MATRICS Consensus Cognitive Battery. Glycated haemoglobin (HbA1), glucose, insulin, and C-peptide levels were determined in plasma. The HOMA-insulin resistance index was calculated. Salivary samples were obtained at home on another day to assess the cortisol awakening response and cortisol levels during the day. Univariate analyses were conducted to explore the association between glucose metabolism parameters and cognitive tasks. For those parameters that were more clearly associated with the cognitive outcome, multiple linear regression analyses were conducted to adjust for covariates. Each cognitive task was considered the dependent variable. Covariates were age, sex, education level, diagnosis, antipsychotic and benzodiazepine treatment, body mass index (BMI), smoking, and HPA axis measures. Potential interactions between diagnosis and glucose parameters were tested. There were no significant differences in HPA axis measures or glucose parameters, with the exception of C-peptide (that was higher in ROP patients), between groups. ROP patients had a lower performance than HS in all cognitive tasks (p < 0.01 for all tasks). Of all glucose metabolism parameters, HbA1c levels were more clearly associated with cognitive impairment in cognitive tasks dealing with executive functions and visual memory in both ROP patients and HS. Multivariate analyses found a significant negative association between HbA1c and cognitive functioning in five cognitive tasks dealing with executive functions, visual memory and attention/vigilance (a ROP diagnosis by HbA1 negative interaction was found in this latter cognitive domain, suggesting that HBA1 levels are associated with impaired attention only in ROP patients). Our study found that HbA1 was negatively associated with cognitive functioning in both ROP patients and HS in tasks dealing with executive functions and visual memory. In ROP patients, HbA1 was also associated with impaired attention. These results were independent of BMI and measures of HPA axis activity.